Developmental actions of natriuretic peptides in the brain and skeleton

Cellular and Molecular Life Sciences

Volumn 61, Issue 18, 2004, Pages 2332-2342

  Waschek, J A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atrial natriuretic peptide (ANP); BNP; CNP; Embryo; Receptor

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GROWTH FACTOR; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C; PARATHYROID HORMONE RELATED PROTEIN; PLATELET DERIVED GROWTH FACTOR A; SONIC HEDGEHOG PROTEIN; VASCULOTROPIN;

ASTROCYTE; BONE GROWTH; BRAIN; BRAIN GROWTH; CARTILAGE CELL; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; EMBRYO DEVELOPMENT; GENE EXPRESSION; HUMAN; IN SITU HYBRIDIZATION; MYELINATION; NERVE CELL; NEURAL TUBE; NONHUMAN; ONTOGENY; PHENOTYPE; PROTEIN EXPRESSION; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCHWANN CELL; SKELETON; SPINAL CORD; VASCULARIZATION;

ANIMALS; BONE DEVELOPMENT; CELL CULTURE TECHNIQUES; CENTRAL NERVOUS SYSTEM; HUMANS; LIGANDS; NATRIURETIC PEPTIDES;

ERINACEIDAE;

EID: 6044224759     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4159-z     Document Type: Review

References (87)

1. Needleman P., Blaine E. H., Greenwald J. E., Michener M. L., Saper C. B., Stockmann P. T. et al. (1989) The biochemical pharmacology of atrial peptides. Ann. Rev. Pharm. Tox. 29: 23-54
2. Espiner E. A., Richards A. M., Yandle T. G. and Nicholls M. G. (1995) Natriuretic hormones. Endocrinol. Metab. Clin. North Am. 24(3): 481-509
3. Nakao K., Ogawa Y., Suga S. I. and Imura H. (1992) Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors. J. Hypertension 10: 1111-1114
4. Anand-Srivastava M. B. and Trachte G. T. (1994) Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol. Rev. 45: 455-497
5. Prins B. A., Weber M. J., Hu R. M., Pedram A., Daniels M. and Levin E. R. (1996) Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. Potential role in the inhibition of astrocyte proliferation. J. Biol. Chem. 271: 14156-14162
6. Silberbach M. and Roberts C. T. (2001) Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cell Signalling 13: 221-231
7. Cameron V. A. and Ellmers L. J. (2003) Minireview: natriuretic peptides during development of the fetal heart and circulation. Endocrinology 144: 2191-2194
8. Walther T. and Stepan H. (2004) C-type natriuretic peptide in reproduction, pregnancy and fetal development. J. Endocrinol. 180: 17-22
9. Appel R. G. (1992) Growth-regulatory properties of atrial natriuretic factor. Am. J. Physiol. 262: F911-F918
10. Horiba N., Nomura K., Saito Y., Demura H. and Shizume K. (1985) Rat atrial natriuretic polypeptide stimulation of adrenal zona glomerulosa cell growth. Biochem. Biophys. Res. Commun. 132: 261-263
11. Appel R. G. (1988) Growth inhibitory activity of atrial natriuretic factor in rat glomerular mesangial cells. FEBS Lett. 238: 135-138
12. Johnson A., Lermioglu F., Garg U. C., Morgan-Boyd R. and Hassid A. (1988) A novel biological effect of atrial natriuretic hormone: inhibition of mesangial cell mitogenesis. Biochem. Biophys. Res. Commun. 152: 893-897
13. Abell T. J., Richards A. M., Ikram H., Espiner E. A. and Yandle T. (1989) Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. Biochem. Biophys. Res. Commun. 160: 1392-1396
14. Kariya K., Kawahara Y., Araki S., Fukuzaki H. and Takai Y. (1989) Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis 80:143-147
15. Moodie S. A. and Martin W. (1991) Effects of cyclic nucleotides and phorbol myristate acetate on proliferation of pig aortic endothelial cells. Br. J. Pharmacol. 102: 101-106
16. Suganami T., Mukoyama M., Sugawara A., Mori K., Nagae T., Kasahara M. et al. (2001) Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. J. Am. Soc. Nephrol. 12: 2652-2663
17. Kasahara M., Mukoyama M., Sugawara A., Makino H., Suganami T., Ogawa Y et al. (2000) Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation. J. Am. Soc. Nephrol. 11: 1691-1701
18. Itoh H. and Nakao K. (1994) Antagonism between the vascular renin-angiotensin and natriuretic peptide systems in vascular remodelling. Blood Press. Suppl. 5: 49-53
19. Brown J., Chen Q. and Hong G. (1997) An autocrine system for C-type natriuretic peptide within rat carotid neointima during arterial repair. Am. J. Physiol. 272: H2919-H2931
20. Ueno H., Haruno A., Morisaki N., Furuya M., Kangawa K., Takeshita A. et al. (1997) Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. Circulation 96: 2272-2279
21. Klinger J. R., Warburton R. R., Pietras L. A., Smithies O., Swift R. and Hill N. S. (1999) Genetic disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxic mice. Am. J. Physiol. 276: L868-L874
22. Zhao L., Long L., Morrell N. W. and Wilkins M. R. (1999) NPR-A-Deficient mice show increased susceptibility to hypoxia-induced pulmonary hypertension. Circulation 99: 605-607
23. Erlebacher A., Filvaroff E. H., Gitelman S. E. and Derynck R. (1995) Toward a molecular understanding of skeletal development. Cell 80: 371-378
24. Horton W. A. (2003) Skeletal development: insights from targeting the mouse genome. Lancet. 362: 560-569
25. Chung U. and Kronenberg H. M. (2000) Parathyroid hormone-related peptide and Indian hedgehog. Curr. Opin. Nephrol. Hypertens. 2000: 357-362
26. Vortkamp A., Lee K., Lanske B., Segre G. V., Kronenberg H. M. and Tabin C. J. (1996) Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273: 613-622
27. Zou H., Choe K. M., Lu Y., Massague J. and Niswander L. (1997) BMP signaling and vertebrate limb development. Cold Spring Harb. Symp. Quant. Biol. 62: 269-272
28. Minina E., Wenzel H. M., Kreschel C., Karp S., Gaffield W., McMahon A. P. et al. (2001) BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 128: 4523-4534
29. St-Jacques B., Hammerschmidt M. and McMahon A. P. (1999) Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13: 2072-2086
30. Amizuka N., Warshawsky H., Henderson J. E., Goltzman D. and Karaplis A. C. (1994) Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J. Cell Biol. 26: 1611-1623
31. Karp S. J., Schipani E., St-Jacques B., Hunzelman J., Kronenberg H. and McMahon A. P. (2000) Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development 127: 543-548
32. Pines M. and Hurwitz S. (1988) The effect of parathyroid hormone and atrial natriuretic peptide on cyclic nucleotides production and proliferation of avian epiphyseal growth plate chondroprogenitor cells. Endocrinology 123: 360-365
33. Hagiwara H., Sakaguchi H., Itakura M., Yoshimoto T., Furuya M., Tanaka S. et al. (1994) Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J. Biol. Chem. 269: 10729-10733
34. Suda M., Ogawa Y., Tanaka K., Tamura N., Yasoda A., Takigawa T. et al. (1998) Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc. Natl. Acad. Sci. USA 95: 2337-2342
35. Yasoda A., Ogawa Y., Suda M., Tamura N., Mori K., Sakuma Y. et al. (1998) Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. J. Biol. Chem. 273: 11695-11700
36. Chusho H., Tamura N., Ogawa Y., Yasoda A., Suda M., Miyazawa T. et al. (2001) Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc. Natl. Acad. Sci. USA 98: 4016-4021
37. Jaubert J., Jaubert F., Martin N., Washburn L. L., Lee B. K., Eicher E. M. et al. (1999) Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene(Npr3). Proc. Natl. Acad. Sci. USA 96: 10278-10283
38. Matsukawa N., Grzesik W. J., Takahashi N., Pandey K. N., Pang S., Yamauchi M. et al. (1999) The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc. Natl. Acad. Sci. USA 96: 7403-7408
39. Miyazawa T., Ogawa Y., Chusho H., Yasoda A., Tamura N., Komatsu Y. et al. (2002) Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification. Endocrinology 143: 3604-3610
40. Tong Y. and Pelletier G. (1990) Ontogeny of atrial natriuretic factor (ANF) binding in various areas of the rat brain. Neuropeptides 16: 63-68
41. Scott J. N. and Jennes L. (1991) Localization of 1251-atrial natriuretic peptide (ANP) in the rat fetus. Anat. Embryol. 183: 245-249
42. Zorad S., Tsutsumi K., Bhatia A. J. and Saavedra J. M. (1993) Localization and characteristics of atrial natriuretic peptide receptors in prenatal and postnatal rat brain. Eur. J. Pharmacol. 241: 195-200
43. Brown J. and Zuo Z. (1995) Natriuretic peptide receptors are expressed during cerebral growth in the fetal rat. Am. J. Physiol. 269: R261-R273
44. DiCicco-Bloom E., Lelièvre V., Zhou X., Rodriguez W., Tam J. and Waschek J. A. (2004) Embryonic expression and multifunctional actions of the natriuretic peptides and receptors in the developing nervous system, Dev. Biol., 18 Feb. [Epub ahead of print]
45. Pringle N. P. and Richardson W. D. (1993) A singularity of PDGF alpha-receptor expression in the dorsoventral axis of the neural tube may define the origin of the oligodendrocyte lineage. Development 117: 525-533
46. Tanabe Y. and Jessell T. M. (1996) Diversity and pattern in the developing spinal cord. Science 274: 1115-1123
47. Lelievre V., Pineau N., Hu Z., Ioffe Y., Byun J. Y., Muller J. M. et al. (2001) Proliferative actions of natriuretic peptides on neuroblastoma cells. Involvement of guanylyl cyclase and non-guanylyl cyclase pathways. J. Biol. Chem. 276: 43668-43676
48. Cameron V. A., Aitken G. D., Ellmers L. J., Kennedy M. A. and Espiner E. A. (1996) The sites of gene expression of atrial, brain and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology 137: 817-824
49. Stepan H., Leitner E., Walter K., Bader M., Schultheiss H., Faber R. et al. (2001) Gestational regulation of the gene expression of C-type natriuretic peptide in mouse reproductive and embryonic tissue. Regul. Pept. 102: 9-13
50. Suga S., Nakao K., Itoh H., Komatsu Y., Ogawa Y., Hama N. et al. (1992) Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of 'vascular natriuretic peptide system'. J. Clin. Invest. 90: 1145-1149
51. Ryan M. C. and Gundlach A. L. (1998) Ontogenic expression of natriuretic peptide mRNAs in postnatal rat brain: implications for development? Brain Res. Dev. Brain Res. 105: 251-268
52. Robertson C. P., Gibbs S. M. and Roelink H. (2001) cGMP enhances the sonic hedgehog response in neural plate cells. Dev. Biol. 238: 157-167
53. Song H., Ming G., He Z., Lehmann M., McKerracher L., Tessier-Lavigne M. et al. (1998) Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science 281: 1515-1518
54. Nishiyama M., Hoshino A., Tsai L., Henley J. R., Goshima Y., Tessier-Lavigne M. et al. (2003) Cyclic AMP/GMP-dependent modulation of Ca2+ channels sets the polarity of nerve growth-cone turning. Nature 424: 990-995
55. Levin E. R. and Frank H. J. (1991) Natriuretic peptides inhibit rat astroglial proliferation: mediation by C receptor. Am. J. Physiol. 261: R453-R457
56. Simpson P. J., Miller I., Moon C., Hanlon A. L., Liebl D. J. and Ronnett G. V. (2002) Atrial natriuretic peptide type C induces a cell-cycle switch from proliferation to differentiation in brain-derived neurotrophic factor- or nerve growth factor-primed olfactory receptor neurons. J. Neurosci. 22: 5536-55351
57. Risau W. (1997) Mechanisms of angiogenesis. Nature 386: 671-674
58. Hungerford J. E. and Little C. D. (1999) Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall. J. Vasc. Res. 36: 2-27
59. Lindahl P., Hellstrom M., Kalen M. and Betsholtz C. (1998) Endothelial-perivascular cell signaling in vascular development: lessons from knockout mice. Curr. Opin. Lipidol. 9: 407-411
60. Breier G. and Risau W. (1996) The role of vascular endothelial growth factor in blood vessel formation. Trends Cell Biol. 6: 454-456
61. Yancopoulos G. D., Klagsbrun M. and Folkman J. (1998) Vasculogenesis, angiogenesis and growth factors: ephrins enter the fray at the border. Cell 93: 661-664
62. Risau W. and Wolburg H. (1990) Development of the blood-brain barrier. Trends Neurosci. 13: 174-178
63. Risau W., Esser S. and Engelhardt B. (1998) Differentiation of blood-brain barrier endothelial cells. Pathol. Biol. 46: 171-175
64. Allt G. and Lawrenson J. G. (1997) Is the pial microvessel a good model for blood-brain barrier studies? Brain Res. Brain Res. Rev. 24: 67-76
65. Balabanov R. and Dore-Duffy P. (1998) Role of the CNS microvascular pericyte in the blood-brain barrier. J. Neurosci. Res. 53: 637-644
66. Plate K. H. (1999) Mechanisms of angiogenesis in the brain. J. Neuropathol. Exp. Neurol. 58: 313-320
67. Risau W., Hallmann R. and Albrecht U. (1986) Differentiation-dependent expression of proteins in brain endothelium during development of the blood-brain barrier. Dev. Biol. 117: 537-545
68. Herken R., Gotz W. and Wattjes K. H. (1989) Initial development of capillaries in the neuroepithelium of the mouse. J. Anat. 164: 85-92
69. Bauer H. C., Bauer H., Lametschwandtner A., Amberger A., Ruiz P. and Steiner M. (1993) Neovascularization and the appearance of morphological characteristics of the blood-brain barrier in the embryonic mouse central nervous system. Brain Res. Dev. Brain Res. 75: 269-278
70. Conradi N. G. and Sourander P. (1980) The early internal vascularization of the rat brain. Morphological studies on foetuses of normal and protein-deprived mothers. Acta Neuropathol. 50: 221-226
71. Breier G., Albrecht U., Sterrer S. and Risau W. (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114: 521-532
72. Smith L. E., Wesolowski E., McLellan A., Kostyk S. K., D'Amato R., Sullivan R. et al. (1994) Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35: 101-111
73. Stone J., Itin A., Alon T., Pe'er J., Gnessin H., Chan-Ling T. et al. (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15: 4738-4747
74. Pierce E. A., Avery R. L., Foley E. D., Aiello L. P. and Smith L. E. (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92: 905-909
75. Provis J. M., Leech J., Diaz C. M., Penfold P., Stone J. and Keshet E. (1997) Development of the human retinal vasculature: cellular relations and VEGF expression. Exp. Eye Res. 65: 555-568
76. Toshimori H., Toshimori K., Oura C. and Matsuo H. (1987) Immunohistochemical study of atrial natriuretic polypeptides in the embryonic, fetal and neonatal rat heart. Cell Tissue Res. 248: 627-633
77. Pedram A., Razandi M., Hu R. M. and Levin E. R. (1997) Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J. Biol. Chem. 272: 17097-17103
78. Neuser D., Stasch J. P., Knorr A. and Kazda S. (1993) Inhibition by atrial natriuretic peptide of endothelin-1-stimulated proliferation of vascular smooth-muscle cells. J. Cardiovasc. Pharmacol. 22 Suppl. 8: S257-S261
79. Cahill P. A. and Hassid A. (1991) Clearance receptor-binding atrial natriuretic peptides inhibit mitogenesis and proliferation of rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 179(3): 1606-1613
80. Kariya K., Kawahara Y., Araki S., Fukuzaki H. and Takai Y. (1989) Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis 80: 143-147
81. Abell T. J., Richards A. M., Ikram H., Espiner E. A. and Yandle T. (1989) Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor Biochem. Biophys. Res. Commun. 160: 1392-1396
82. Itoh H., Pratt R. E., Ohno M. and Dzau V. J. (1992) Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension 19: 758-761
83. Ikeda M., Kohno M., Yasunari K., Yokokawa K., Horio T., Ueda M. et al. (1997) Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17: 731-736
84. Kohno M., Yokokawa K., Yasunari K., Kano H., Minami M., Ueda M. et al. (1997) Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Circ. Res. 81: 585-590
85. Haefliger I. O. and Anderson D. R. (1997) Oxygen modulation of guanylate cyclase-mediated retinal pericyte relaxations with 3-morpholino-sydnonimine and atrial natriuretic peptide. Invest. Ophthalmol. Vis. Sci. 38: 1563-1568
86. Pedram A., Razandi M. and Levin E. R. (2002) Deciphering vascular endothelial cell growth factor/vascular permeability factor signaling to vascular permeability. Inhibition by atrial natriuretic peptide. J. Biol. Chem. 277: 44385-44398
87. Kook H., Itoh H., Choi B. S., Sawada N., Doi K., Hwang T. J. et al. (2003) Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro. Am. J. Physiol. Heart Circ. Physiol. 284: H1388-H1397